Image

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Investigational Treatment for Metastatic Pancreatic Adenocarcinoma

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates metastatic pancreatic adenocarcinoma. It looks at how effective a combination of investigational medications is for this condition.

The purpose of this study is to evaluate the safety and effectiveness of the investigational medication combination. This includes looking at how these medications affect the body and if there are any side effects.

  • Who can participate: Adults 18 years and older with metastatic pancreatic adenocarcinoma can participate. Participants should not have had prior treatments for this condition and must meet specific health criteria, such as a certain ECOG performance status.
  • Study details: Participants will receive investigational medications. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine. Participants will undergo regular evaluations to monitor the treatment's effects and any side effects.
Print
Study details
    Adenocarcinoma of the Pancreas

NCT05821556

National Cancer Institute, Naples

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.